HighPoint Advisor Group’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-605
Closed -$181K 443
2019
Q3
$181K Sell
605
-335
-36% -$100K 0.04% 334
2019
Q2
$455K Buy
940
+27
+3% +$13.1K 0.11% 165
2019
Q1
$439K Buy
913
+7
+0.8% +$3.37K 0.11% 175
2018
Q4
$581K Buy
906
+180
+25% +$115K 0.15% 146
2018
Q3
$435K Sell
726
-30
-4% -$18K 0.12% 179
2018
Q2
$680K Buy
756
+302
+67% +$272K 0.18% 138
2018
Q1
$369K Buy
+454
New +$369K 0.1% 206
2017
Q4
Sell
-1,220
Closed -$431K 313
2017
Q3
$431K Buy
+1,220
New +$431K 0.13% 177